Where does Disc Medicine's cash flow data come from?

Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Disc Medicine IRON Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$241.6M-13.9%	-$212.18M-17.2%	-$181.11M-24.6%	-$145.39M-24.8%	-$116.49M-6.5%
Depreciation and amortization	$350K+24.6%	$281K+39.8%	$201K+60.8%	$125K-16.7%	$150K-3.8%
Stock-based compensation	$39.92M+16.3%	$34.34M+19.9%	$28.63M+22.1%	$23.45M+22.6%	$19.12M+13.7%
Change in accounts payable	$5.09M+376%	$1.07M—	——	——	——
Change in accrued liabilities	$1.84M-73.3%	$6.88M+44.5%	$4.76M+268%	$1.29M+148%	-$2.68M-259%
Change in other assets	$6.61M-28.9%	$9.29M+59.4%	$5.83M—	——	——
Other working capital changes	$26K+2,700%	-$1K—	——	——	——
Change in operating lease liabilities	——	——	——	$276K+1,740%	$15K+103%
Net cash from operating activities	-$201.25M-11.6%	-$180.39M-9.6%	-$164.67M-22.7%	-$134.23M-32.0%	-$101.7M-8.3%
Capital expenditures	$82K-91.2%	$933K-31.5%	$1.36M—	——	——
Proceeds from maturities/sales of investments	$532.82M+16.8%	$456.22M+16.2%	$392.62M+39.9%	$280.62M+64.8%	$170.27M+79.6%
Net cash from investing activities	——	——	——	——	-$564.9M-93.2%
Proceeds from issuance of debt	——	$0-100%	$7.25M-50.0%	$14.49M-33.3%	$21.74M-25.0%
Proceeds from issuance of common stock	$9.08M+5.0%	$8.64M+106%	$4.2M—	——	——
Net cash from financing activities	$230.85M-51.2%	$473.41M+65.8%	$285.53M+4.1%	$274.37M-38.6%	$446.67M+105%
Net increase (decrease) in cash	——	——	——	——	-$219.94M-31.0%
Interest paid	$2.74M-2.1%	$2.8M+20.8%	$2.31M+44.2%	$1.61M+79.1%	$896K+353%
Accretion (Amortization) of Discounts and Premiums, Investments	$7.06M-17.1%	$8.52M-6.4%	$9.1M-7.7%	$9.86M+25.9%	$7.83M+47.6%
Increase Decrease In Accrued External Research And Development Expenses	$4.72M+9.4%	$4.31M—	——	——	——
Operating lease liabilities	——	——	——	$276K+1,740%	$15K+103%
Accrued liabilities	$1.84M-73.3%	$6.88M+44.5%	$4.76M—	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	$6.61M-28.9%	$9.29M+59.4%	$5.83M—	——	——
Non Cash Interest Expense	$836K-0.1%	$837K+11.2%	$753K+38.9%	$542K+62.3%	$334K+163%
Noncash Lease Expense	$490K+3.6%	$473K+3.3%	$458K+22.5%	$374K-7.2%	$403K-6.9%
Other Noncash Income (Expense)	$26K+2,700%	-$1K—	——	——	——
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale	$532.82M+16.8%	$456.22M+16.2%	$392.62M+39.9%	$280.62M+64.8%	$170.27M+79.6%
Payments Of Debt Issuance Costs	——	$0-100%	$348.25K-50.0%	$696.5K-33.3%	$1.04M-25.0%
Proceeds From Sale Of Common Stock In Underwritten Offering Net Of Issuance Costs Paid	——	——	——	——	——
Proceeds From Sale Of Pre Funded Warrants In Underwritten Offerings Net Of Issuance Costs Paid	——	——	——	——	$9.39M—
Proceeds from issuance of common stock relating to employee stock plans	——	——	——	——	——
Increase Decrease In Operating Lease Liability	——	——	——	$276K+1,740%	$15K+103%
Operating Lease Payments	——	$850K+4.0%	$817K+4.2%	$784K+4.4%	$751K+4.6%
Free cash flow	-$201.34M-11.0%	-$181.33M-9.2%	-$166.03M-22.5%	-$135.56M-31.6%	-$102.99M-9.1%
Free cash flow	-$201.34M-11.0%	-$181.33M-9.2%	-$166.03M-22.5%	-$135.56M-31.6%	-$102.99M-9.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Disc Medicine's cash flow data come from?: Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.